$TirzepatidePriceGuide
Head-to-head comparison

Ro vs Henry Meds

Ro centers on FDA-approved brand-name tirzepatide with insurance support; Henry Meds offers lower-cost compounded tirzepatide via async intake. Here's how they compare.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
 Ro BodyHenry Meds
From / month$349+/mo$297/mo
Medication typeBrand (Zepbound/Mounjaro)Compounded tirzepatide
FDA statusFDA-approvedNot FDA-approved
Clinical oversightMD-ledClinician + async intake
Pharmacy / fulfillmentManufacturer / retail503A compounding pharmacy
InsurancePrior-auth supportCash-pay (HSA/FSA)

Pricing verified as of July 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.

Clinical model

Ro is MD-led and focuses on brand-name Zepbound/Mounjaro with help navigating insurance prior authorization. Henry Meds uses an asynchronous intake with compounded tirzepatide on the 503A pathway. Eligibility is clinician-determined in both cases.

Pharmacy & fulfillment

Ro fulfills through manufacturer/retail pharmacy channels; Henry Meds uses 503A compounding pharmacies. Compounded products are not FDA-approved.

Pros & trade-offs

Strengths and trade-offs

Ro Body

Strengths
  • FDA-approved brand-name product
  • Insurance prior-auth assistance
  • MD-led
Trade-offs
  • Higher cash cost
  • Coverage-dependent pricing

Henry Meds

Strengths
  • Lower-cost compounded option
  • Convenient async intake
  • Established platform
Trade-offs
  • Not FDA-approved (compounded)
  • Asynchronous model

Who each may be best for

Ro may suit those who want a brand-name product or insurance pathways. Henry Meds may suit cash-pay patients prioritizing low cost and convenience. For a flat-rate compounded alternative, see the NexLife review.

Top pick · flat-rate compounded
$115/mo*
All doses one price · coaching included
See NexLife pricing →
FAQ

Questions

Is Ro or Henry Meds cheaper?

Henry Meds (compounded, ~$297/mo) is generally cheaper cash-pay than Ro (brand, $349+/mo), but Ro's product is FDA-approved and may be insurance-assisted. Compounded tirzepatide is not FDA-approved. See NexLife pricing

Brand vs compounded — what's the difference?

Ro dispenses FDA-approved brand-name tirzepatide; Henry Meds dispenses compounded tirzepatide prepared by a 503A pharmacy, which is not FDA-approved.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Keep comparing

Related comparisons & cost guides